Participating sites

PneumoINSPIRE contributors

Pneumonia has a wide-ranging and diverse impacts on ICUs across the world. It is these various impacts and motivators that attract researchers worldwide to the PneumoINSPIRE study.  Below is feedback from some of our major collaborators and national coordinators regarding pneumonia’s affect on their ICU and why they decided to participate in PneumoINSPIRE. 


Kostoula Arvaniti, Monitoring Committee &  National Coordinator of Greece

PneumoINSPIRE appeared since the beginning as a really ambitious project on a common clinical entity in the ICU setting, endorsed by important scientific societies. The prospective and multinational multicentre design of the study was promising regarding collection or real-world data on diagnostic and therapeutic management of hospital- and ventilator-associated pneumonia patients. Moreover, it aims to give to each ICU center and country, a great opportunity for rational comparisons between their own setting and the international cohort, thus facilitating future prevention and treatment strategies amelioration. Pneumonia remains a principal cause of ICU admission and an important cause of overall mortality despite numerous scientific advances on prevention and treatment policies. I hope the results from this international database will help identify specific risk factors of mortality and parameters affecting appropriate antibiotic treatment (e.g. multidrug resistance, inadequately performed diagnostic procedures, confused scientific guidelines on appropriateness and indication of various diagnostic sampling techniques, ICU and hospital organizational issues, etc.)


Jordi Rello, Steering Committee & National Coordinator of  Spain

This project will show a real picture on the complexity and diversity of respiratory infections in MV patients. PneumoINSPIRE is a global collaborative effort to advance on the challenge of updating the understanding of VAP. An old-problem. A new perspective.


Vladimir Shatalov, Principal Investigator of Core Site in Russia

In our ICU, nosocomial pneumonia often develops in patients undergoing prolonged mechanical ventilation. Most of these patients have acute brain damage (stroke, trauma). In patients with another pathologies, nosocomial pneumonia develops quite rarely. In this study, I would like to know how nosocomial pneumonia is diagnosed in different countries, what the pathogens of pneumonia are more common and to what antibiotics they are most sensitive. I decided to participate in this study because it was interesting for me to work in a large international team of researchers. I wanted to get experience with observational study for my future work.


Jep Palo, National Coordinator of Philippines

We decided to participate in PneumoINSPIRE to understand our own patients with pneumonia, as well as to contribute to the world's knowledge for taking care of ICU patients with severe pneumonias. We thought it important, not only for the clinical aspect, but for the institutional learning that we gain from collaborating with researchers worldwide. Pneumonia is one of the top reasons for an admission to ICU in our Philippine setting and it was important to share our experience as well as audit our local practices.


Rosa Reina, National Coordinator of Argentina and Spanish protocol translator

This study will provide up-to-date and generalisable information on diagnosis and management of nosocomial pneumonia. Because this is a multi-centre study, carried out worldwide, PneumoINSPIRE will give us important information about nosocomial pneumonia.


Andrea Cortegiani, National Co-Coordinator of Italy & Principal Investigator of Core Site

Pneumonia is the most commonly encountered infection and is the most important complication of medium-long term mechanical ventilation. It is the clear main reason to try to speed up weaning process (in Italian, I would say "Damocle's sword over patient's head"). Big epidemiological studies are the only way to get useful information to improve the care of critically ill patients. PneumoINSPIRE has the methodological quality to be a landmark study With this study I hope to see more information on risk factors for pneumonia and treatment failure, prognosis and effects of different therapeutic strategies.


Boris Belotserkovski, Principal Investigator of Core Site in Russia

Pneumonia is a serious threat for my patients. Successful prevention and treatment of this complication in the era of high resistance will save a lot of lives. I hope to find out  the real epidemiological situation and etiology of nosocomial pneumonia in different countries. I don`t believe that the real rate on VAP is close to zero.

PneumoINSPIRE team

Sean Montgomery, Medical Student at the University of Queensland - Ochsner Clinical School

As a medical student from the United States, I chose to study in Australia because I am interested in the larger picture of medicine, which includes an appreciation for global health issues and practices. PneumoINSPIRE attracted me immediately because the study is seeking information from healthcare practitioners around the world. Understanding the methods surrounding the diagnosis, complications and treatment of pneumonia on a deeper level is of paramount importance. PneumoINSPIRE is an ambitious endeavor, and I am excited that my work on this project may help further knowledge surrounding pneumonia, ultimately reducing mortality for patients worldwide. 


Bruno Perthus, Medical Student at the University of Queensland - Ochsner Clinical School

I decided to volunteer as an extracurricular researcher for the PneumoINSPIRE study because as an aspiring Infectious Disease physician I have a strong interest in pneumonia. Pneumonia has such a profound effect on our global  healthcare system, and it is obvious that any progress that can be made to improve our knowledge, and thereby our treatment protocols, for this debilitating disease would be incredibly impactful. I am very excited and proud to be able to be a part of the PneumoINSPIRE study because I am aware that there are immense benefits that can be reaped from the data that is being collected.